Prophylactic and therapeutic efficacy of poly(I,C)-LC against Rift Valley fever virus infection in mice

scientific article published on October 1985

Prophylactic and therapeutic efficacy of poly(I,C)-LC against Rift Valley fever virus infection in mice is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID2416883

P2093author name stringM Kende
P433issue5
P921main subjectRift Valley feverQ326638
Rift Valley fever virusQ14276794
Rift Valley fever phlebovirusQ24809101
P304page(s)503-511
P577publication date1985-10-01
P1433published inJournal of biological response modifiersQ27711629
P1476titleProphylactic and therapeutic efficacy of poly(I,C)-LC against Rift Valley fever virus infection in mice
P478volume4

Reverse relations

cites work (P2860)
Q64450546Antiviral therapeutic approaches for human rhinovirus infections
Q35165344Association of symptoms and severity of rift valley fever with genetic polymorphisms in human innate immune pathways
Q27487859Broad-Spectrum Drugs Against Viral Agents
Q39195523NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase
Q26747457Phleboviruses and the Type I Interferon Response
Q35120421Prophylactic and therapeutic efficacies of poly(IC.LC) against respiratory influenza A virus infection in mice
Q45324172Recent advances in the development of antiviral therapeutics for Rift Valley fever virus infection.
Q26745530Rift Valley fever virus NSs protein functions and the similarity to other bunyavirus NSs proteins
Q38195597TLR Agonists as Modulators of the Innate Immune Response and Their Potential as Agents Against Infectious Disease.
Q55379440Use of Toll-Like Receptor 3 Agonists Against Respiratory Viral Infections.

Search more.